Industry Academia Alliances


Asia/Qatar Industry Academia Alliances Save the date Hilton Hotel Doha Research doj2006@qatar-med.cornell.edu AT Hilton Hotel Doha

Gabriele Ronnett, MD, PhD

Gabriele Ronnett
Disease Interception Venture Leader, Gestational Diabetes and Obesity
Compound Development Team Leader
The Janssen Pharmaceutical Companies of Johnson & Johnson
New Jersey, USA

Dr. Ronnett has served as the Gestational Diabetes (GDM) Venture Leader in the Disease Interception Accelerator (DIA) at Janssen Research & Development within Johnson & Johnson.  She was Professor of Neuroscience, Neurology, and Biological Chemistry at Johns Hopkins University School of Medicine, where she was also the Founding Director of the Center for Metabolism and Obesity Research (CMOR) and one of the Founding Directors of the Center for Integrated Resources in Biology at Johns Hopkins. Dr. Ronnett also served as the founding Director and Head of the Department of Brain Sciences, the first such department in Korea, at the Daegu Gyeongbuk Institute of Science and Technology (DGIST) in the Republic of Korea. She received her MD and PhD in Biochemistry from The Johns Hopkins University School of Medicine.  She performed her Medical Internship on the Osler Medical Service, her Neurology Residency, and then was Chief Resident in Neurology at the Johns Hopkins Hospital. Her research has been in diverse fields, including obesity, diabetes, cancer, autism, olfaction, and stroke.